down arrow

Valiant Organics

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE565V01010
  • NSEID: VALIANTORG
  • BSEID: 540145
INR
360.00
5.4 (1.52%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 48.59 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

356.70379.60

52 Week

225.00455.20
Valuation
Technical
Day's Volume

CASH

48.59 k (-70.29%) Volume

Shareholding (Dec 2024)

FII

0.82%

Held by 16 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

37.74%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -139.10% of over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

Risky - Negative Operating Profits

5

Falling Participation by Institutional Investors

6

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 994 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

-4.51%

stock-summary
Price to Book

1.37

Revenue and Profits (1 Year):
Net Sales:
187 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-9.33%
0%
-9.33%
1 Year
-16.22%
0%
-16.22%
2 Years
-21.8%
0%
-21.8%
3 Years
-64.11%
0.63%
-63.48%
4 Years
-75.66%
0.25%
-75.41%
5 Years
-40.0%
1.46%
-38.54%

Latest dividend: 1 per share ex-dividend date: Feb-10-2023

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.38%
EBIT Growth (5y)
-139.10%
EBIT to Interest (avg)
17.32
Debt to EBITDA (avg)
2.77
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.01
Tax Ratio
8.28%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.82%
ROCE (avg)
15.71%
ROE (avg)
13.45%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
1.37
EV to EBIT
-314.21
EV to EBITDA
37.09
EV to Capital Employed
1.29
EV to Sales
1.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.64%
ROE (Latest)
-4.51%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 16 FIIs (0.82%)

Promoter with highest holding

Jaya Chandrakant Gogri (8.37%)

Highest Public shareholder

Nikhil Parimal Desai (9.1%)

Individual Investors Holdings

37.12%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 32.19% vs -43.54% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 169.20% vs -135.91% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "186.86",
          "val2": "141.36",
          "chgp": "32.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.33",
          "val2": "3.78",
          "chgp": "305.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.83",
          "val2": "4.19",
          "chgp": "39.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.46",
          "val2": "-7.89",
          "chgp": "169.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.20%",
          "val2": "2.67%",
          "chgp": "5.53%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -18.98% vs -23.60% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -180.14% vs -54.05% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "328.09",
          "val2": "404.94",
          "chgp": "-18.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18.07",
          "val2": "39.35",
          "chgp": "-54.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "13.15",
          "val2": "8.14",
          "chgp": "61.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.75",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-13.40",
          "val2": "16.72",
          "chgp": "-180.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.51%",
          "val2": "9.72%",
          "chgp": "-4.21%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -5.74% vs -30.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -189.92% vs -84.87% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "514.95",
          "val2": "546.30",
          "chgp": "-5.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33.40",
          "val2": "43.13",
          "chgp": "-22.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.98",
          "val2": "12.33",
          "chgp": "53.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.75",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.94",
          "val2": "8.83",
          "chgp": "-189.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.49%",
          "val2": "7.89%",
          "chgp": "-1.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -31.25% vs -8.80% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -109.52% vs -22.21% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "723.06",
          "val2": "1,051.80",
          "chgp": "-31.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "38.25",
          "val2": "164.23",
          "chgp": "-76.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "16.34",
          "val2": "10.79",
          "chgp": "51.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.41",
          "val2": "4.90",
          "chgp": "-169.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.39",
          "val2": "88.12",
          "chgp": "-109.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.29%",
          "val2": "15.61%",
          "chgp": "-10.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
186.86
141.36
32.19%
Operating Profit (PBDIT) excl Other Income
15.33
3.78
305.56%
Interest
5.83
4.19
39.14%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.46
-7.89
169.20%
Operating Profit Margin (Excl OI)
8.20%
2.67%
5.53%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 32.19% vs -43.54% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 169.20% vs -135.91% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
328.09
404.94
-18.98%
Operating Profit (PBDIT) excl Other Income
18.07
39.35
-54.08%
Interest
13.15
8.14
61.55%
Exceptional Items
0.00
5.75
-100.00%
Consolidate Net Profit
-13.40
16.72
-180.14%
Operating Profit Margin (Excl OI)
5.51%
9.72%
-4.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -18.98% vs -23.60% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -180.14% vs -54.05% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
514.95
546.30
-5.74%
Operating Profit (PBDIT) excl Other Income
33.40
43.13
-22.56%
Interest
18.98
12.33
53.93%
Exceptional Items
0.00
5.75
-100.00%
Consolidate Net Profit
-7.94
8.83
-189.92%
Operating Profit Margin (Excl OI)
6.49%
7.89%
-1.40%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -5.74% vs -30.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -189.92% vs -84.87% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
723.06
1,051.80
-31.25%
Operating Profit (PBDIT) excl Other Income
38.25
164.23
-76.71%
Interest
16.34
10.79
51.44%
Exceptional Items
-3.41
4.90
-169.59%
Consolidate Net Profit
-8.39
88.12
-109.52%
Operating Profit Margin (Excl OI)
5.29%
15.61%
-10.32%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -31.25% vs -8.80% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -109.52% vs -22.21% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Valiant Organics Ltd stock-summary
stock-summary
Valiant Organics Ltd
Micro Cap
Pharmaceuticals & Drugs
Valiant Organics Limited was incorporated as 'Valiant Organics Private Limited' on February 06, 2005 in Mumbai, Maharashtra. The status of the Company was changed to a Public Limited Company and the name was changed to 'Valiant Organics Limited' vide fresh Certificate of Incorporation on July 31, 2015 by the Registrar of Companies, Mumbai, and Maharashtra. The Company is a specialty chemical manufacturing for Agro Intermediate and Pharma in India.
Company Coordinates stock-summary
Company Details
109 Udyog Kshetra 1st Floor, Mulund Goregaon Link Rd Mulund Mumbai Maharashtra : 400080
stock-summary
Tel: 91-22-25913767/3766/67976640/5
stock-summary
http://www.valiantorganics.com
stock-summary
investor@valiantorganics.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."